Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 12:10:105-115.
doi: 10.2147/HMER.S140711. eCollection 2018.

Acute pediatric hyperammonemia: current diagnosis and management strategies

Nadia Savy  1 , David Brossier  2 , Catherine Brunel-Guitton  1 , Laurence Ducharme-Crevier  1 , Geneviève Du Pont-Thibodeau  1 , Philippe Jouvet  1
Affiliations
Review

Acute pediatric hyperammonemia: current diagnosis and management strategies

Nadia Savy et al. Hepat Med. .

Abstract

Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies.

Keywords: critical care; hemodialysis; hyperammonemia; pediatrics; sodium benzoate; sodium phenylacetate.

PubMed Disclaimer

Conflict of interest statement

Disclosure P. Jouvet has received financial support from the Fonds de Recherche Santé Québec and from the Quebec Ministry of Health as well as from Sainte-Justine University Hospital. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Putative mechanisms underlying hyperammonemia encephalopathy and brain edema.
Figure 2
Figure 2
Diagnostic algorithm facing hyperammonemia Note: Adapted from Haberle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32. Abbreviations: AR1D, arginase 1 deficiency; ASLD, arginosuccinate lyase deficiency; ASSD, arginosuccinate synthetase deficiency; CPS1-D, carbamoylphosphate synthetase 1 deficiency; NAGS-D, N-acetylglutamate synthetase deficiency; OTCD, ornithine transcarbamylase deficiency.
Figure 3
Figure 3
Urea cycle and therapies for hyperammonemia. Notes: Each number corresponds to a urea cycle deficiency disease: 1 = N-acetylglutamate synthase; 2 = carbamoylphosphate synthetase 1; 3 = ornithine transcarbamylase; 4 = arginosuccinate synthetase; 5 = arginosuccinate lyase; 6 = arginase deficiency. Abbreviation: CoA, coenzyme A.
Figure 4
Figure 4
Suggested algorithm for management of hyperammonemia symptomatic patients according to Guideline Development Group – Grade of recommendation C–D. Source: Adapted from Haberle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32. Abbreviations: CPS1D, carbamoylphosphate synthetase 1 deficiency; IV, intravenous; NAGSD, N-acetylglutamate synthetase deficiency; OTCD, ornithine transcarbamylase deficiency; TCD, transcranial Doppler; UCD, urea cycle defect.
See this image and copyright information in PMC

References

    1. Ozanne B, Nelson J, Cousineau J, et al. Threshold for toxicity from hyperammonemia in critically ill children. J Hepatol. 2012;56(1):123–128. - PubMed
    1. Hakvoort TB, He Y, Kulik W, et al. Pivotal role of glutamine synthetase in ammonia detoxification. Hepatology. 2017;65(1):281–293. - PubMed
    1. Auron A, Brophy PD. Hyperammonemia in review: pathophysiology, diagnosis, and treatment. Pediatr Nephrol. 2012;27(2):207–222. - PubMed
    1. Wijdicks EF. Hepatic encephalopathy. N Engl J Med. 2016;375(17):1660–1670. - PubMed
    1. Paprocka J, Jamroz E. Hyperammonemia in children: on the crossroad of different disorders. Neurologist. 2012;18(5):261–265. - PubMed